Zhitong Finance App learned that 3D Medicines Inc. (01244) issued an insider information notice disclosing that the arbitration case involving the company and SELLAS Life Sciences Group, Inc. (hereinafter referred to as “SELLAS”) has reached a significant positive ruling. The arbitration was fully adjudicated by the Hong Kong International Arbitration Centre, which handed down the final ruling after hearing by a sole arbitrator.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.